Institution
Glenfield Hospital
Healthcare•Leicester, United Kingdom•
About: Glenfield Hospital is a healthcare organization based out in Leicester, United Kingdom. It is known for research contribution in the topics: Population & Extracorporeal membrane oxygenation. The organization has 1382 authors who have published 1812 publications receiving 99238 citations. The organization is also known as: Glenfield General Hospital.
Topics: Population, Extracorporeal membrane oxygenation, Asthma, Genome-wide association study, Lung cancer
Papers published on a yearly basis
Papers
More filters
••
University of Lübeck1, University of Tartu2, Stanford University3, Harvard University4, Wellcome Trust Centre for Human Genetics5, University of Oxford6, Science for Life Laboratory7, University of Tampere8, Queen Mary University of London9, Heidelberg University10, Icahn School of Medicine at Mount Sinai11, University of Leicester12, Glenfield Hospital13, University of Ottawa14, University of Pennsylvania15, Leipzig University16, Broad Institute17, Samsung Medical Center18, Technische Universität München19, Imperial College London20, Ealing Hospital21, Population Health Research Institute22, Harokopio University23, French Institute of Health and Medical Research24, Duke University25, University of Leeds26, Karolinska Institutet27, Cleveland Clinic28, Uppsala University29, Massachusetts Institute of Technology30, University of Liverpool31, National Institutes of Health32, Lebanese American University33, Imperial College Healthcare34, Kaiser Permanente35, Medical University of Graz36, Synlab Group37, University of Helsinki38, University of Oklahoma Health Sciences Center39, King Abdulaziz University40, Wellcome Trust Sanger Institute41
TL;DR: A comprehensive X-chromosome-wide meta-analysis including more than 43,000 CAD cases and 58,000 controls from 35 international study cohorts found none of the investigated models revealed genome-wide significant associations for any variant.
Abstract: In recent years, genome-wide association studies have identified 58 independent risk loci for coronary artery disease (CAD) on the autosome. However, due to the sex-specific data structure of the X chromosome, it has been excluded from most of these analyses. While females have 2 copies of chromosome X, males have only one. Also, one of the female X chromosomes may be inactivated. Therefore, special test statistics and quality control procedures are required. Thus, little is known about the role of X-chromosomal variants in CAD. To fill this gap, we conducted a comprehensive X-chromosome-wide meta-analysis including more than 43,000 CAD cases and 58,000 controls from 35 international study cohorts. For quality control, sex-specific filters were used to adequately take the special structure of X-chromosomal data into account. For single study analyses, several logistic regression models were calculated allowing for inactivation of one female X-chromosome, adjusting for sex and investigating interactions between sex and genetic variants. Then, meta-analyses including all 35 studies were conducted using random effects models. None of the investigated models revealed genome-wide significant associations for any variant. Although we analyzed the largest-to-date sample, currently available methods were not able to detect any associations of X-chromosomal variants with CAD.
24 citations
••
TL;DR: To study the reproducibility of the measurement of shoulder movement, a series of 64 patients with and without shoulder problems are examined, measuring active elevation, abduction, and external rotation in adduction using an inclinometer.
Abstract: To study the reproducibility of the measurement of shoulder movement, we have examined a series of 64 patients with and without shoulder problems, measuring active elevation, abduction, and external rotation in adduction using an inclinometer. The difference within which readings by different observers were expected to lie for 95% of the pairs of observations ranged from 24° to 33° for different movements in asymptomatic shoulders and from 24° to 41° in those with unilateral shoulder symptoms awaiting surgery.
24 citations
••
TL;DR: TRM provides regional quantitative information on changes in inhaled gas ventilation in response to therapy and could be used as a sensitive regional outcome metric for novel respiratory interventions.
Abstract: Purpose To assess the magnitude of regional response to respiratory therapeutic agents in the lungs by using treatment response mapping (TRM) with hyperpolarized gas magnetic resonance (MR) imaging. TRM was used to quantify regional physiologic response in adults with asthma who underwent a bronchodilator challenge. Materials and Methods This study was approved by the national research ethics committee and was performed with informed consent. Imaging was performed in 20 adult patients with asthma by using hyperpolarized helium 3 (3He) ventilation MR imaging. Two sets of baseline images were acquired before inhalation of a bronchodilating agent (salbutamol 400 μg), and one set was acquired after. All images were registered for voxelwise comparison. Regional treatment response, ΔR(r), was calculated as the difference in regional gas distribution (R[r] = ratio of inhaled gas to total volume of a voxel when normalized for lung inflation volume) before and after intervention. A voxelwise activation threshold from the variability of the baseline images was applied to ΔR(r) maps. The summed global treatment response map (ΔRnet) was then used as a global lung index for comparison with metrics of bronchodilator response measured by using spirometry and the global imaging metric percentage ventilated volume (%VV). Results ΔRnet showed significant correlation (P < .01) with changes in forced expiratory volume in 1 second (r = 0.70), forced vital capacity (r = 0.84), and %VV (r = 0.56). A significant (P < .01) positive treatment effect was detected with all metrics; however, ΔRnet showed a lower intersubject coefficient of variation (64%) than all of the other tests (coefficient of variation, ≥99%). Conclusion TRM provides regional quantitative information on changes in inhaled gas ventilation in response to therapy. This method could be used as a sensitive regional outcome metric for novel respiratory interventions. © RSNA, 2017 Online supplemental material is available for this article.
24 citations
••
24 citations
••
TL;DR: Fungal involvement in asthma is associated with severe disease and the full spectrum of fungal species in asthma are not well described and are derived largely from insensitive culture techniques.
Abstract: BACKGROUND:Fungal involvement in asthma is associated with severe disease. The full spectrum of fungal species in asthma is not well described and is derived largely from insensitive culture techniques. OBJECTIVES:To use high-throughput sequencing to describe the airway mycobiota in asthmatics with and without fungal-sensitisation and healthy controls; to compare samples representing different airway compartments; to determine if the mycobiota was influenced by the fungal composition of outdoor air, and to compare findings with clinically relevant outcomes. METHODS:We amplified the internal transcribed spacer region 2 of the nuclear ribosomal operon to identify the fungal species present. Ninety-seven subjects were recruited and provided sputum (83 asthmatics; 14 healthy subjects), with 29 also undergoing a bronchoscopy. A subset of airway samples were compared with matched outdoor air and mouthwash samples. RESULTS:Two hundred and six taxa at the species level were identified in sputum, most at low relative abundance. Aspergillus fumigatus, Candida albicans and Mycosphaerella tassiana had the highest relative abundances and were the most prevalent species across all subjects. The airway mycobiota consisted of a complex community with high diversity between individuals. Notable shifts in the balance of fungi detected in the lung were associated with asthma status, asthma duration and biomarkers of inflammation. Aspergillus tubingensis, a member of the Aspergillus niger species complex, was most prevalent from bronchoscopic protected brush samples and significantly associated with a low sputum neutrophilia. Cryptococcus pseudolongus, from the Cryptococcus humicola species complex, was more abundant from bronchoscopy samples than sputum, and differentially more abundant in asthma than health. CONCLUSIONS AND CLINICAL RELEVANCE:The airway mycobiota was dominated by a relatively small number of species, but was distinct from the oropharyngeal mycobiota and air samples. Members of the Aspergillus niger and Cryptococus humicola species complexes may play unexpected roles in the pathogenesis of asthma.
23 citations
Authors
Showing all 1385 results
Name | H-index | Papers | Citations |
---|---|---|---|
Nilesh J. Samani | 149 | 779 | 113545 |
Daniel I. Chasman | 134 | 484 | 72180 |
Massimo Mangino | 116 | 369 | 84902 |
Ian D. Pavord | 108 | 575 | 47691 |
Christopher E. Brightling | 103 | 552 | 44358 |
Ulf Gyllensten | 100 | 368 | 59219 |
Pim van der Harst | 99 | 517 | 42777 |
Andrew J. Wardlaw | 92 | 311 | 33721 |
Kenneth J. O'Byrne | 87 | 629 | 39193 |
Paul Burton | 85 | 418 | 42766 |
Bryan Williams | 82 | 454 | 40798 |
Marylyn D. Ritchie | 80 | 459 | 32559 |
John R. Thompson | 78 | 202 | 50475 |
Maria G. Belvisi | 73 | 269 | 16021 |
Martin D. Tobin | 72 | 218 | 34028 |